Computational Selectivity Assessment of Protease Inhibitors against SARS-CoV-2.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
19 Feb 2021
Historique:
received: 04 01 2021
revised: 08 02 2021
accepted: 11 02 2021
entrez: 6 3 2021
pubmed: 7 3 2021
medline: 17 3 2021
Statut: epublish

Résumé

The pandemic of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a serious global health threat. Since no specific therapeutics are available, researchers around the world screened compounds to inhibit various molecular targets of SARS-CoV-2 including its main protease (M

Identifiants

pubmed: 33669738
pii: ijms22042065
doi: 10.3390/ijms22042065
pmc: PMC7922391
pii:
doi:

Substances chimiques

Antiviral Agents 0
Protease Inhibitors 0
Peptide Hydrolases EC 3.4.-
3C-like proteinase, SARS-CoV-2 EC 3.4.22.-
Coronavirus 3C Proteases EC 3.4.22.28

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

J Chem Inf Model. 2010 Jan;50(1):123-35
pubmed: 20058856
Bioinformatics. 2020 Apr 15;36(8):2599-2601
pubmed: 31860077
Int J Mol Sci. 2020 May 21;21(10):
pubmed: 32455534
Curr Top Med Chem. 2006;6(1):41-55
pubmed: 16454757
Science. 2020 Jun 19;368(6497):1331-1335
pubmed: 32321856
Nucleic Acids Res. 2019 Jan 8;47(D1):D1102-D1109
pubmed: 30371825
Proteins. 1999 Nov 15;37(3):379-87
pubmed: 10591098
J Phys Chem Lett. 2020 Jun 4;11(11):4413-4420
pubmed: 32406687
Nat Rev Drug Discov. 2018 May;17(5):353-377
pubmed: 29545548
Cell Res. 2020 Apr;30(4):343-355
pubmed: 32231345
J Chem Inf Model. 2016 Dec 27;56(12):2281-2286
pubmed: 27808512
Nat Rev Drug Discov. 2012 Dec;11(12):909-22
pubmed: 23197038
J Comput Aided Mol Des. 2013 Mar;27(3):221-34
pubmed: 23579614
Cell Res. 2020 Aug;30(8):678-692
pubmed: 32541865
J Med Chem. 2016 Dec 8;59(23):10383-10399
pubmed: 27486927
Int J Antimicrob Agents. 2020 Aug;56(2):106055
pubmed: 32534187
Molecules. 2020 May 29;25(11):
pubmed: 32485894
Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W665-7
pubmed: 15215472
J Chem Theory Comput. 2015 Aug 11;11(8):3696-713
pubmed: 26574453
Sci Rep. 2019 Sep 10;9(1):13053
pubmed: 31506468
Bioinformatics. 2012 Apr 15;28(8):1166-7
pubmed: 22368248
Nucleic Acids Res. 2017 Jan 4;45(D1):D955-D963
pubmed: 27899599
J Med Chem. 2012 Jul 26;55(14):6582-94
pubmed: 22716043
Nucleic Acids Res. 2000 Jan 1;28(1):235-42
pubmed: 10592235
JAMA. 2020 May 19;323(19):1897-1898
pubmed: 32208486
Blood. 2020 Jun 4;135(23):2033-2040
pubmed: 32339221
J Chem Inf Model. 2013 Aug 26;53(8):1893-904
pubmed: 23379370
Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515
pubmed: 30395287
Toxicol Lett. 2015 Jan 22;232(2):519-32
pubmed: 25240273
J Chem Theory Comput. 2010 Mar 9;6(3):607-624
pubmed: 20440377
Protein Sci. 1995 Mar;4(3):337-60
pubmed: 7795518
Structure. 2009 Dec 9;17(12):1636-1648
pubmed: 20004167
J Comput Chem. 2012 Jul 5;33(18):1536-43
pubmed: 22522665
Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10037-41
pubmed: 11517324
J Chem Theory Comput. 2015 Jul 14;11(7):3199-210
pubmed: 26575757
Proc Natl Acad Sci U S A. 2021 Mar 9;118(10):
pubmed: 33597253
Nat Chem Biol. 2009 May;5(5):358-64
pubmed: 19305397
Nat Rev Drug Discov. 2015 Jul;14(7):475-86
pubmed: 26091267
Int J Mol Sci. 2020 Jan 14;21(2):
pubmed: 31947677
Life Sci. 2020 Jun 15;251:117627
pubmed: 32251634
Nucleic Acids Res. 2014 Jan;42(Database issue):D297-303
pubmed: 24319143
J Thromb Haemost. 2020 May;18(5):1094-1099
pubmed: 32220112
Lancet. 2005 Feb 19-25;365(9460):682-6
pubmed: 15721475
Nature. 2020 Jun;582(7811):289-293
pubmed: 32272481
Nucleic Acids Res. 2012 Jul;40(Web Server issue):W537-41
pubmed: 22570416
Chem Rev. 2019 Aug 28;119(16):9478-9508
pubmed: 31244000
Proc IEEE Comput Syst Bioinform Conf. 2004;:372-81
pubmed: 16448030
SLAS Discov. 2019 Jan;24(1):1-24
pubmed: 30196745
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Int J Mol Sci. 2020 Apr 28;21(9):
pubmed: 32353978
J Comput Aided Mol Des. 2018 Jan;32(1):163-173
pubmed: 28836076
Nucleic Acids Res. 1994 Nov 11;22(22):4673-80
pubmed: 7984417
J Genet Genomics. 2020 Feb 20;47(2):119-121
pubmed: 32173287
J Chem Inf Model. 2017 Jun 26;57(6):1388-1401
pubmed: 28537745
J Med Chem. 2004 Mar 25;47(7):1750-9
pubmed: 15027866
J Infect Public Health. 2020 Sep;13(9):1210-1223
pubmed: 32561274
Methods Mol Biol. 2017;1611:123-134
pubmed: 28451976

Auteurs

André Fischer (A)

Computational Pharmacy, Departement of Pharmaceutical Sciences, University of Basel, 4056 Basel, Switzerland.

Manuel Sellner (M)

Computational Pharmacy, Departement of Pharmaceutical Sciences, University of Basel, 4056 Basel, Switzerland.

Karolina Mitusińska (K)

Tunneling Group, Biotechnology Centre, ul. Krzywoustego 8, Silesian University of Technology, 44-100 Gliwice, Poland.

Maria Bzówka (M)

Tunneling Group, Biotechnology Centre, ul. Krzywoustego 8, Silesian University of Technology, 44-100 Gliwice, Poland.

Markus A Lill (MA)

Computational Pharmacy, Departement of Pharmaceutical Sciences, University of Basel, 4056 Basel, Switzerland.

Artur Góra (A)

Tunneling Group, Biotechnology Centre, ul. Krzywoustego 8, Silesian University of Technology, 44-100 Gliwice, Poland.

Martin Smieško (M)

Computational Pharmacy, Departement of Pharmaceutical Sciences, University of Basel, 4056 Basel, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH